Previous Page  35 / 50 Next Page
Information
Show Menu
Previous Page 35 / 50 Next Page
Page Background

33

Contenido disponible en

www.neumologia-pediatrica.cl

6. Muenzer J, Wraith J, Clarke L. Mucopolysaccharidosis I:

Management and Treatment Guidelines. Pediatrics 2009; 123: 19-

29.

7. Giugliani R, Harmatz P, Wraith J. Management Guidelines for

Mucopolysaccharidosis VI. Pediatrics 2007; 120: 405-18.

8. Ashworth J, Biswas S, Wraith E, Lloyd Ch. Mucopolysaccharidoses

and the Eye. Surv Ophthalmol 2006; 51: 1-17.

9. Morishita K, Petty R. Musculoskeletal manifestations of muco-

polysaccharidoses. Rheumatology 2011; 50: 19-25.

10. White K. Orthopaedic aspects of mucopolysaccharidoses.

Rheumatology 2011; 50: 26-33.

11. Braunlin E, Harmatz P, Scarpa M, Furlanetto B, Kampmann C,

Loehr JP, Ponder K, Roberts W, Rosenfeld H, Giugliani R. Cardiac

disease in patients with mucopolysaccharidosis: presentation,

diagnosis and management. J Inherit Metab Dis 2011; 34: 1183-

97.

12. Valayannopoulos V, Wijburg F. Therapy for the mucopoly-

saccharidoses. Rheumatology 2011; 50: 49-59.

13. Clarke L, Heppner J. Mucopolysaccharidosis Type I. Gene Reviews.

http://www.ncbi.nlm.nih.gov/books/NBK1162

(2 de septiembre de

2012).

14. Scarpa M. Mucopolysaccharidosis Type II. Gene Reviews. http://

www.ncbi.nlm.nih.gov/books/NBK1274 (2 de septiembre de

2012).

15. Valstar M, Marchal JP, Grootenhuis M, Colland V, Wijburg F.

Cognitive development in patients with Mucopolysaccharidosis

type III (Sanfilippo syndrome). Orphanet J Rare Dis 2011; 6: 43-8.

16. Muenzer J. The Mucopolysaccharidoses: a heterogeneous group

of disorders with variable pediatric presentations. J Pediatr 2004;

144: S27-S34.

17. Fundación Chilena de Pacientes con Enfermedades Lisosomales.

www.felch.cl

(3 de agosto de 2012).

18. Santos S, López L, González L, Domínguez MJ. Hipoacusia y

problemas de vía aérea en niños con mucopolisacaridosis. Acta

Otorrinolaringol Esp 2011; 62: 411-7.

19. Motamed M, Thorne, S, Narula A. Treatment of otitis media

with effusion in children with mucopolysaccharidoses. Int J Pediatr

Otorhinolaryngol 2000; 53: 121-4.

20. Dempsey J, Veasey S, Morgan B, O’Donnell C. Pathophysiology of

Sleep Apnea. Physiol Rev 2010; 90: 47-112.

21. Leighton S, Papsin B, Vellodi A, Dinwiddie D, Lane R. Disordered

breathing during sleep in patients with mucopolysaccharidoses. Int

J Pediatr Otorhinolaryngol 2001; 58: 127-38.

22. Shih S, Lee J, Lin S, Sheu Y, Blickman J. Airway changes in children

with mucopolysaccharidosis. Acta Radiologica 2002; 43: 40-3.

23. Nagano R, Takizawa Sh, Hayama N, Umemura Sh, Uesugi T,

Nakagawa S, et al. Three-dimensional CT and histopathological

findings of airway Malacia in Hunter Syndrome. J Exp Clin Med

2007; 32: 59-61.

24. John Â, Fagondes S, Schwartz I, Azevedo AC, Barrios P,

Dalcin P, et al. Sleep abnormalities in untreated patients with

mucopolysaccharidosis type VI. Am J Med Genet 2011; 155: 1546-

51.

25. Jeong HS,

Cho DY, Ahn KM, Jin DY. Complications of tracheotomy

in patients with mucopolysaccharidoses type II (Hunter syndrome).

Int J Pediatr Otorhinolaryngol 2006; 70: 1765-9.

26. Ingelmo PM, Parini R, Grimaldi M, Mauri F, Romagnoli M,

Tagliabue G, et al. Multidetector computed tomography

(MDCT) for preoperative airway assessment in children with

mucopolysaccharidoses. Minerva Anestesiol 2011; 77: 774-80.

27. Kamin W. Diagnosis and management of respiratory involvement

in Hunter syndrome. Acta Pædiatrica 2008; 97; 57-60.

28. Hope E, Farebrother M, Bainbridge D. Some aspects of respiratory

function in three siblings with Morquio-Brailsford disease. Thorax

1969; 28: 335-41.

29. Harmatz P, Yu ZF, Giugliani R, Schwartz IV, Guffon N, et al. Enzyme

replacement therapy for mucopolysaccharidosis VI: evaluation of

long-term pulmonary function in patients treated with recombinant

human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis

2010; 33: 51-60.

30. Kirkpatrick K, Ellwood J, Walker R. Mucopolysaccharidosis type I

(Hurler syndrome) and anesthesia: the impact of bone marrow

transplantation, enzyme replacement therapy, and fiberoptic

intubation on airway management. Pediatr Anesth 2012 (22): 745-

51.

31. Davitt S, Hatrick A, Sabharwal T, Pearce A, Gleeson M, Adam A.

Tracheobronchial stent insertions
in the management of major

airway obstruction in a patient with Hunter syndrome (type-II

mucopolysaccharidosis). Eur Radiol 2002; 12: 458-62.

32. Rodríguez M, Mackenzie W, Ditro C, Miller T, Chidekel A, Shaffer

T. Skeletal Dysplasias: Evaluation With Impulse Oscillometry and

Thoracoabdominal Motion Analysis. Pediatr Pulmonol 2010; 45:

679-86.

33. Wraith J, Clarke L, Beck M, Kolodny E, Pastores G, Muenzer J,

et al. Enzyme replacement therapy for mucopolysaccharidosis I:

a randomized, double-blinded, placebo-controlled, multinational

study of recombinant human a-l-iduronidase (laronidase). J Pediatr

2004; 144: 581-8.

34. Wraith J. Enzyme replacement therapy with idursulfase in patients

with mucopolysaccharidosis type II. Acta Pædiatr 2008; 97: 76-8.

35. Harmatz P, Ketteridge D, Giugliani R, Guffon G, Teles E, Miranda

M, et al. Direct Comparison of Measures of Endurance, Mobility,

and Joint Function During Enzyme-Replacement Therapy of

Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results

After 48 Weeks in a Phase 2 Open-Label Clinical Study of

Recombinant Human N-Acetylgalactosamine 4-Sulfatase. Pediatrics

2005; 115: e681-9.

36. Arna P, Whitley Ch, Wraith J, Webba H, Underhill L, Rangachari

L, et al. High rate of postoperative mortality in patients with

mucopolysaccharidosis I: findings from the MPS I Registry. J Pediatr

Surg 2012; 47: 477-84.

37. Frawley G, Fuenzalida D, Donath S, Yaplito-Lee J, Peters H. A

retrospective audit of anesthetic techniques and complications in

children with mucopolysaccharidoses. Pediatr Anesth 2012; 22:

737-44.

38. Theroux M, Nerker T, Ditro C, Mackenzie W. Anesthetic care and

perioperative complications of children with Morquio síndrome.

Pediatr Anesth 2012; 22: 901–7.

39. Shinhar Sh, Zablocki H, Madgy D. Airway Management in

Mucopolysaccharide Storage Disorders. Arch Otolaryngol Head

Neck Surg 2004; 130: 233-7.

40. Walker R, Colovic V, Robinson D, Dearlove O. Postobstructive

Pulmonary Oedema During Anaesthesia In Children With

Mucopolysaccharidoses. Paediatr Anaesth 2003; 13: 441-7.

Compromiso respiratorio en mucopolisacaridosis - J. Hernández

Neumol Pediatr 2013; 8 (1): 27-33.